Back to search

Article

Harnessing ALDH1A2 vulnerability in T-cell acute lymphoblastic leukemia

2025-03-14

Abstract excerpt

T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive hematologic malignancy with limited therapeutic options, particularly in the relapsed/refractory (R/R) setting. Unlike other hematological malignancies, which benefit from targeted immunotherapies, T-ALL remains reliant on chemotherapy, leading to poor outcomes in R/R cases. Identifying novel therapeutic vulnerabilities is crucial to improving the outcom...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
5e269fbf-1ba3-52b5-a06b-d83910ad6ed8
DOI
10.1101/2025.03.11.642712
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Harnessing ALDH1A2 vulnerability in T-cell acute lymphoblastic leukemiaDOI 10.1101/2025.03.11.642712
Select a neighboring publication to make it the new centre.